Treace Medical Concepts (NASDAQ: TMCI) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.31) by 9.68 percent. This is a 12 percent decrease over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $47.198 million which beat the analyst consensus estimate of $45.960 million by 2.69 percent. This is a 10.22 percent decrease over sales of $52.570 million the same period last year.